Factor VIIa-albumin fusion protein regulatory update

FDA granted Orphan Drug designation for CSL's rVIIa-FP to treat and prevent bleeding episodes in patients with congenital hemophilia and inhibitors to coagulation Factors VIII or IX. The preclinical r...